Furthermore, sub-clinical changes in thyroid hormone levels are common, may still require treatment, or at least monitoring, and therefore reporting by CTCAE criteria can underestimate the true incidence of thyroid hormone abnormalities, without clearly separating those with Graves’ disease requiring a different treatment paradigm. Here, TG is linked to Graves disease.